Celiac Disease Gluten-intolerance
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults (patients and control subjects UMCG & Martini Ziekenhuis Groningen; controls Wilhelmina Ziekenhuis Assen): -Patients suffering from CeD diagnosed by the treating physician according to established clinical, serological and pathological definitions. - Patients suffering from IBS as diagnosed by the treating physician according to established clinical defined in the Rome II criteria. -Spouses and 1st line family members of CeD patients - >= 18- years old;Children (Patienten Wilhelmina Ziekenhuis Assen): -Patients suffering from CeD diagnosed by the treating physician according to established clinical, serological and pathological definitions. -
Exclusion criteria
Exclusion criteria: not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary study parameters will be the data sets generated by the different 'omics' approaches and the results of the integration of these datasets. | — |
Secondary
| Measure | Time frame |
|---|---|
| These analyses will identify CeD biomarkers and the identification of these will provide novel insights into the etiopathology of CeD. This will help in the future with improving diagnostics and treatment, and hopefully the prevention of CeD. | — |
Countries
Netherlands